| domain | spryson.com |
| summary | NeuroAI has received FDA Breakthrough Designation, expediting the regulatory approval process for their innovative technology. They've published groundbreaking research in Experimental Brain Research titled "Oculomotor, Vestibular, Reaction Time, and Cognitive OVRT-C Responses in 7- to 17-Year-Old Children." This study offers novel insights into neurological function in children, focusing on eye-tracking, balance, reaction time, and cognition. The research advances pediatric brain health, concussion recovery, and cognitive development studies. This publication underscores NeuroAIs technology as a leading AI-driven diagnostic tool for enhancing brain health understanding and improvement. |
| title | Home - Spryson America |
| description | Home - Spryson America |
| keywords | research, technology, tracking, data, more, time, menu, platform, concussion, check, diagnostics, real, detection, objective, main, chair, breakthrough |
| upstreams |
|
| downstreams |
|
| nslookup | A 162.159.135.42 |
| created | 2025-11-10 |
| updated | 2025-11-10 |
| summarized | 2025-11-12 |
|
|